“…Most therapeutic strategies target this particular stage of biofilm formation, rendering it significant to understand the mechanism of bacterial adhesion . The primary attachment of bacteria to the implant surface is driven by nonspecific and reversible factors, including Lifshitz–van der Waal forces, hydrophobic interactions, and electrostatic interactions. , Filamentous bacterial cell appendages (e.g., pili, the nanofibers) facilitate strong adhesion of bacterial cells with the surface. , When an implant is introduced in the human body, components of the immune system and extracellular matrix (ECM) proteins get rapidly adsorbed on its surface. ECM components, mainly fibronectin (Fn) and collagen, mediate bacterial adhesion by specifically binding to bacterial adhesion molecules known as microbial surface components recognizing adhesive matrix molecules (MSCRAMMs). , For instance, to promote adhesion, MSCRAMMs such as collagen-binding adhesin (CNA) and fibronectin-binding proteins (FnBPs) interact specifically with collagen and Fn, respectively (Figure B). − Another essential species-specific adhesion protein, autolysin, is also involved in bacterial adhesion.…”